You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海利爾(603639.SH):子公司噻蟲嗪和噻蟲胺原藥項目試生產
格隆匯 06-22 15:36

格隆匯 6 月 22日丨海利爾(603639.SH)公佈,公司所屬全資子公司山東海利爾化工有限公司(“山東海利爾”)自有資金建設的第二代煙鹼類殺蟲劑噻蟲嗪原藥和噻蟲胺原藥項目已完成工程主體建設及設備安裝、調試工作,近日試生產方案經專家評審通過,符合試生產條件,正式進入試生產階段。

雙噻項目的建成投產符合公司的戰略規劃,有助於進一步豐富公司原藥產品品種。若項目全面投產,將有助於公司在主業穩定發展的基礎上,增加新的利潤增長點,提高公司市場綜合競爭力和盈利能力。該項目投產運營將對公司未來經營業績產生積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account